Eriosema laurentii De Wild (Leguminosae) methanol extract has estrogenic properties and prevents menopausal symptoms in ovariectomized Wistar rats.

[1]  A. Nahrstedt,et al.  What Is the Best Strategy for Preclinical Testing of Botanicals? A Critical Perspective , 2012, Planta Medica.

[2]  M. A. Mvondo,et al.  A postmenopause-like model of ovariectomized Wistar rats to identify active principles of Erythrina lysistemon (Fabaceae). , 2011, Fitoterapia.

[3]  C. Fokunang,et al.  Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon. , 2011, African Journal of Traditional Complementary and Alternative Medicines.

[4]  R. Recker,et al.  Phosphate and carbonate salts of calcium support robust bone building in osteoporosis. , 2010, American Journal of Clinical Nutrition.

[5]  A. Jungbauer,et al.  Comparison of hormonal activity of isoflavone-containing supplements used to treat menopausal complaints , 2009, Menopause.

[6]  W. Wuttke,et al.  Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats. , 2008, Journal of Endocrinology.

[7]  Anders G. Olsson,et al.  Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment , 2008, Circulation.

[8]  A. Jungbauer,et al.  Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  X. Coumoul.  Dioxine et œstradiol - L’amour vache ou une histoire de « complexes » , 2007 .

[10]  A. Bitto,et al.  Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study , 2007, Menopause.

[11]  V. Beral.  Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[12]  S. Ryu,et al.  The Effect of Menopause on the Metabolic Syndrome Among Korean Women , 2007, Diabetes Care.

[13]  J. Gustafsson,et al.  Estrogen Receptor (ER) β Modulates ERα-Mediated Transcriptional Activation by Altering the Recruitment of c-Fos and c-Jun to Estrogen-Responsive Promoters , 2006 .

[14]  G. Vollmer,et al.  Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  Masayuki Yamamoto,et al.  Intrinsic Function of the Aryl Hydrocarbon (Dioxin) Receptor as a Key Factor in Female Reproduction , 2005, Molecular and Cellular Biology.

[16]  M. Nakajima,et al.  Cytochrome P450-mediated metabolism of estrogens and its regulation in human. , 2005, Cancer Letters.

[17]  H Kuhl,et al.  Pharmacology of estrogens and progestogens: influence of different routes of administration , 2005, Climacteric : the journal of the International Menopause Society.

[18]  S. X. Wang,et al.  In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. , 2005, Journal of ethnopharmacology.

[19]  M. Dobiášová.  Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications. , 2004, Clinical chemistry.

[20]  A. Bitto,et al.  Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. , 2004, Menopause.

[21]  S. Nam,et al.  Evaluation of the Preventive Effect of Isoflavone Extract on Bone Loss in Ovariectomized Rats , 2004, Bioscience, biotechnology, and biochemistry.

[22]  K. Meldrum,et al.  The role of estrogen in cardiovascular disease. , 2003, The Journal of surgical research.

[23]  Chris P. Miller,et al.  Constrained Phytoestrogens and Analogues as ERβ Selective Ligands. , 2003 .

[24]  Mark Garton,et al.  Breast cancer and hormone-replacement therapy: the Million Women Study , 2003, The Lancet.

[25]  K. Korach,et al.  Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. , 2003, Molecular endocrinology.

[26]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[27]  Chris P. Miller,et al.  Constrained phytoestrogens and analogues as ERbeta selective ligands. , 2003, Bioorganic & medicinal chemistry letters.

[28]  Stephen Safe,et al.  The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes , 2003, Molecular and Cellular Biology.

[29]  A. Cassidy.  Potential risks and benefits of phytoestrogen-rich diets. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[30]  G. Bifulco,et al.  Effects of genistein on the endometrium: ultrasonographic evaluation , 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[31]  A. Jungbauer,et al.  Yeast reporter system for rapid determination of estrogenic activity. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  Robert W. Moore,et al.  Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[34]  I. Goldstein,et al.  Role of androgens in female genital sexual arousal: receptor expression, structure, and function. , 2002, Fertility and sterility.

[35]  T. Clarkson,et al.  Estrogen replacement therapy, atherosclerosis, and vascular function. , 2002, Cardiovascular research.

[36]  J. Gustafsson,et al.  Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male Mice , 2000 .

[37]  S. Curtis Hewitt,et al.  Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice - what their phenotypes reveal about mechanisms of estrogen action , 2000, Breast Cancer Research.

[38]  S. Safe,et al.  Mechanisms of Inhibitory Aryl Hydrocarbon Receptor-Estrogen Receptor Crosstalk in Human Breast Cancer Cells , 2000, Journal of Mammary Gland Biology and Neoplasia.

[39]  V. Coxam,et al.  Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. , 2000, The Journal of nutrition.

[40]  E. Jensen,et al.  Estrogen receptor (ER) , a modulator of ER in the uterus , 2000 .

[41]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[42]  C. Vecchia,et al.  The Adverse Effects of Hormone Replacement Therapy , 1999, Drugs & aging.

[43]  Susan R. Johnson,et al.  Symptom Relief and Side Effects of Postmenopausal Hormones: Results From the Postmenopausal Estrogen/Progestin Interventions Trial , 1998, Obstetrics and gynecology.

[44]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[45]  A. Fornace,et al.  The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. , 1998, Molecular pharmacology.

[46]  K. Korach,et al.  Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.

[47]  J. Buring,et al.  Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. , 1997, Circulation.

[48]  J. Gaughan,et al.  Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. , 1997, The Journal of endocrinology.

[49]  G. Bruscalupi,et al.  Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. , 1996, Biochemical and biophysical research communications.

[50]  R. Krauss,et al.  Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. , 1996, American journal of obstetrics and gynecology.

[51]  R T Turner,et al.  Skeletal effects of estrogen. , 1994, Endocrine reviews.

[52]  L. Tenkanen,et al.  Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study , 1992 .

[53]  Vesa Manninen,et al.  Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment , 1992, Circulation.

[54]  B. Rosner,et al.  Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. , 1991, The New England journal of medicine.

[55]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[56]  J. Auwerx,et al.  Development, food intake, and ethinylestradiol influence hepatic triglyceride lipase and LDL-receptor mRNA levels in rats. , 1990, Journal of lipid research.

[57]  W. Hazzard,et al.  Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. , 1989, Journal of lipid research.

[58]  C. Slemenda,et al.  Baseline measurement of bone mass predicts fracture in white women. , 1989, Annals of internal medicine.

[59]  T. Wronski,et al.  Skeletal alterations in ovariectomized rats , 1985, Calcified Tissue International.

[60]  L. Schenkel,et al.  17 beta-estradiol for postmenopausal estrogen replacement therapy. , 1984, Obstetrical & gynecological survey.

[61]  Y. Chao,et al.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. , 1980, The Journal of biological chemistry.

[62]  R. Cruess,et al.  The effect of long term estrogen administration on bone metabolism in the female rat. , 1979, Endocrinology.

[63]  C. Wade,et al.  Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. , 1978, Toxicology and applied pharmacology.

[64]  M. Hamosh,et al.  The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. , 1975, The Journal of clinical investigation.

[65]  C. Glueck,et al.  Effects of estrogenic compounds on triglyceride kinetics. , 1975, Metabolism: clinical and experimental.

[66]  J. Dalziel,et al.  The useful plants of West Tropical Africa. , 1938 .

[67]  L. Cardozo,et al.  Urogenital Prolapse and Atrophy at Menopause: A Prevalence Study , 2014, International Urogynecology Journal.

[68]  J. Gustafsson,et al.  Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. , 2006, Molecular endocrinology.

[69]  V. Beral,et al.  Endometrial cancer and hormone-replacement therapy in the Million Women Study. , 2005, Lancet.

[70]  B. Carr,et al.  Estrogens , 2004, Reviews in Endocrine & Metabolic Disorders.

[71]  B. O’Malley,et al.  Reproductive functions of progesterone receptors. , 2002, Recent progress in hormone research.

[72]  Sac-fry Stages,et al.  OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .

[73]  J. Gustafsson,et al.  Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. , 2000, Biochemical and biophysical research communications.

[74]  V. Beral,et al.  Use of HRT and the subsequent risk of cancer. , 1999, Journal of epidemiology and biostatistics.

[75]  Robert A. Mueller,et al.  Principles of pharmacology : basic concepts and clinical applications , 1995 .

[76]  T. Wronski,et al.  Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. , 1986, Bone.

[77]  A. T. Bryant.  Zulu Medicine and Medicine-Men , 1983 .

[78]  J. Morton.  Atlas of Medicinal Plants of Middle America: Bahamas to Yucatan , 1980 .